Vanda Pharmaceuticals says its schizophrenia drug works in bipolar disorder


“We believe this is really critical data to ask for an FDA approval,” said Vanda’s president and CEO.

Previous Former Truist CFO joins New York bank
Next Denver-area property managers acted as “price-fixing cartel” to keep rents elevated, class-action lawsuit alleges